首頁 > 市場調查報告書 > 製藥

市場調查報告書

商品編碼

2046632

顯微鏡成像試劑市場：全球產業規模、佔有率、趨勢、機會和預測（按類型、應用和地區分類），競爭格局（2021-2031 年）

Microscopy Imaging Reagents Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By Region & Competition, 2021-2031F

出版日期: 2026年05月25日 | 出版商:

TechSci Research | 英文 185 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

全球顯微成像試劑市場預計將從 2025 年的 20.8 億美元成長到 2031 年的 26.1 億美元，複合年成長率為 3.86%。

這些試劑，包括螢光染料和抗體等生物探針，是專門開發的化學配方，旨在提高顯微鏡下細胞結構的特異性和可見性。市場成長的主要驅動力是生命科學研究投資的大幅增加，以及為應對慢性病日益增多帶來的負擔而迫切需要精準的診斷工具。藥物研發過程中對高性能耗材的持續需求進一步推動了這一成長趨勢，確保了對具有高靈敏度和高解析度試劑的穩定需求。

市場概覽
預測期	2027-2031
市場規模（2025 年）	20.8億美元
市場規模（2031年）	26.1億美元
複合年成長率（2026-2031）	3.86%
快速成長的細分市場	免疫細胞化學試劑
最大的市場	北美洲

儘管發展勢頭強勁，但該行業仍面臨諸多挑戰，包括高昂的實施成本以及先進螢光染料固有的技術穩定性難題。這些財務和技術障礙往往阻礙了預算有限的小規模學術機構和診斷檢查室獲得相關技術。然而，醫療創新領域的大量投資為該領域提供了支持，進而推動了耗材的使用。根據歐洲製藥工業協會聯合會（EFPIA）2024年的報告顯示，歐洲製藥業每年投入約550億歐元用於研發，這凸顯了強大的資金基礎，為這些關鍵成像工具的消費提供了支撐。

市場促進因素

全球癌症和慢性神經系統疾病發生率的不斷上升是顯微鏡診斷試劑市場的主要驅動力，也因此迫切需要先進的工具來促進早期檢測和病理研究。隨著這些疾病負擔的加重，臨床檢查室和研究機構需要高特異性的染色劑和螢光染料，以便更準確地識別蛋白質聚集和細胞異常。這種需求與需要診斷干預和長期監測的患者數量不斷增加直接相關。例如，美國癌症協會於2024年1月發布的《2024年癌症事實與數據》報告預測，當年美國新增癌症病例將達到2,001,140例，這將需要更多的檢測試劑和免疫組織化學標記物來處理日益成長的生物檢體量。

同時，生物技術和製藥領域研發投入的激增也顯著推動了市場擴張。這是因為影像診斷對於藥物發現中的表現型篩檢和標靶檢驗至關重要。各公司正大力投資產品管線開發，並尋求穩定的影像耗材供應，以便觀察細胞對新型化合物的反應。根據羅氏公司於2024年2月發布的2023年度報告，該公司已投資132億瑞士法郎用於研發，以增強其製藥和診斷能力。除了這些企業支出外，公共部門為穩定市場生態系統所做的努力也在促進市場發展。例如，美國國立衛生研究院（NIH）2024年的最終批准預算為471億美元，用於支持生物醫學研究，並確保為構成影像試劑核心基本客群的學術機構提供持續的資金支持。

市場挑戰

先進螢光染料的高成本和技術穩定性問題是全球顯微鏡診斷試劑市場擴張的主要障礙。大型製藥企業能夠承擔這些成本，但獨立診斷實驗室和小規模學術機構往往面臨嚴重的資金限制，阻礙了高性能耗材的普及應用。這種資金差距造成了市場結構的分層。最靈敏、最精確的成像能力集中在少數資金雄厚的機構手中，導致先進診斷工作流程的標準化進程停滯不前，並限制了其市場滲透率。

近期聯邦政府削減科研經費進一步加劇了這種經濟壓力，限制了實驗室採購的資金來源。根據美國醫學院協會（AAMC）的數據，2024年7月至2025年6月期間，美國國立衛生研究院（NIH）提供給美國研究機構的研究經費比前一年減少了約47億美元。外部資金的急劇下降迫使研究機構減少對高品質試劑的可自由支配支出，這反過來又直接抑制了整個成像試劑產業的銷售量，並阻礙了收入成長。

市場趨勢

隨著研究人員將空間生物學技術作為可視化複雜組織微環境的優先手段，多色和多重成像試劑的日益普及正在從根本上改變市場格局。這一趨勢包括從單一生物標記分析轉向高參數表現型分析，從而能夠在單一樣本中同時檢測數十種不同的RNA轉錄物和蛋白質。由於這些先進檢測技術能夠提供傳統免疫組織化學無法揭示的疾病病理和細胞異質性的關鍵訊息，因此對其的需求正在加速成長。為了佐證這一轉變，Akoya Biosciences在其2024年5月發布的2024年第一季財報中指出，引用其太空生物學技術的論文總數同比成長了52%，表明這些先進的成像工作流程正在迅速獲得科學檢驗和應用。

此外，針對自動化和高內涵篩檢最佳化的試劑正蓬勃發展。這主要源自於製藥業對透過高通量表現型分析加速藥物發現的需求。這一趨勢要求開發專用檢測試劑盒和螢光染料，以確保其在長時間的自動化採集週期中保持穩定性，並最大限度地減少大規模篩檢宣傳活動中的變異性。因此，自動化儀器的市場應用正在激增，徵兆試劑消耗量將持續成長。例如，Standard BioTools 在 2024 年 2 月發布的 2023 年第四季及全年財報中指出，2023 年全年儀器銷售額成長了 46%，顯示依賴這些先進耗材配方的高參數分析系統數量正在強勁成長。

The Global Microscopy Imaging Reagents Market is projected to expand from USD 2.08 Billion in 2025 to USD 2.61 Billion by 2031, reflecting a compound annual growth rate of 3.86%. These reagents, which encompass biological probes such as fluorophores and antibodies, are specialized chemical formulations developed to improve the specificity and visibility of cellular structures during microscopic examination. The market's growth is primarily fueled by a significant increase in capital directed toward life sciences research and the urgent need for precise diagnostic tools to address the rising burden of chronic diseases. This upward trajectory is further supported by the continuous demand for high-performance consumables within drug discovery processes, ensuring a steady requirement for reagents that offer superior sensitivity and resolution.

Market Overview
Forecast Period	2027-2031
Market Size 2025	USD 2.08 Billion
Market Size 2031	USD 2.61 Billion
CAGR 2026-2031	3.86%
Fastest Growing Segment	Immunocytochemistry Reagents
Largest Market	North America

Despite this strong momentum, the industry faces notable hurdles related to the high acquisition costs and technical stability challenges inherent to advanced fluorescent dyes. These financial and technical barriers often restrict access for smaller academic institutions and diagnostic laboratories operating with limited budgets. Nevertheless, the sector is supported by substantial investment in medical innovation, which drives the usage of consumables. As reported by the European Federation of Pharmaceutical Industries and Associations in 2024, the pharmaceutical sector allocated approximately €55 billion to research and development across Europe, highlighting the robust financial infrastructure that sustains the consumption of these essential imaging tools.

Market Driver

The escalating global prevalence of cancer and chronic neurological conditions acts as a major catalyst for the microscopy imaging reagents market, creating a critical need for advanced tools to facilitate early detection and pathological research. As the burden of these diseases grows, clinical and research laboratories require highly specific stains and fluorophores to identify protein aggregations and cellular anomalies with greater precision. This demand is directly linked to the expanding patient population that requires diagnostic intervention and long-term monitoring. For instance, the American Cancer Society's 'Cancer Facts & Figures 2024' report, released in January 2024, projects 2,001,140 new cancer cases in the United States for the year, necessitating a higher volume of detection chemistries and immunohistochemical markers to process the increasing load of biological samples.

Simultaneously, the surge in biotechnology and pharmaceutical research and development investments is significantly propelling market expansion, as drug discovery relies heavily on imaging for phenotypic screening and target validation. Corporations are channeling vast amounts of capital into pipeline development, demanding a consistent supply of imaging consumables to observe cellular responses to novel compounds. According to Roche's 'Annual Report 2023' published in February 2024, the company invested CHF 13.2 billion in research and development to enhance its pharmaceutical and diagnostic capabilities. This corporate spending is complemented by public sector initiatives that stabilize the market ecosystem; for example, the National Institutes of Health operated with a final enacted budget of $47.1 billion in 2024 to support biomedical research, ensuring sustained funding for the academic institutions that form a core customer base for imaging reagents.

Market Challenge

The prohibitive costs and technical stability issues associated with advanced fluorescent dyes present a significant barrier to the expansion of the global microscopy imaging reagents market. While major pharmaceutical companies can absorb these expenses, independent diagnostic laboratories and smaller academic institutions often face rigid fiscal constraints that hinder the adoption of high-performance consumables. This financial disparity creates a tiered market structure, where the most sensitive and precise imaging capabilities are concentrated within a limited number of well-funded organizations, effectively stalling the standardization of advanced diagnostic workflows and limiting broader market penetration.

This economic pressure is further intensified by recent reductions in federal support for scientific research, which restricts the capital available for laboratory procurement. Data from the Association of American Medical Colleges indicates that in 2025, the National Institutes of Health obligated approximately $4.7 billion less in research funding to U.S. institutions between July 2024 and June 2025 compared to the previous year. Such a sharp decrease in external funding forces research facilities to curtail discretionary spending on premium reagents, thereby directly suppressing sales volumes and hampering the overall revenue growth of the imaging reagents sector.

Market Trends

The increasing adoption of reagents for multicolor and multiplexed imaging is fundamentally reshaping the market, as researchers prioritize spatial biology techniques to visualize complex tissue microenvironments. This trend involves a shift from single-biomarker analysis to high-parameter phenotyping, allowing for the simultaneous detection of dozens of distinct RNA transcripts or proteins within a single sample. The demand for these sophisticated detection chemistries is accelerating because they provide critical insights into disease pathology and cellular heterogeneity that traditional immunohistochemistry cannot reveal. Highlighting this shift, Akoya Biosciences reported in their 'First Quarter 2024 Financial Results' in May 2024 a 52% year-over-year increase in total publications citing their spatial biology technologies, underscoring the rapid scientific validation and uptake of these advanced imaging workflows.

Additionally, the rise of reagents optimized for automation and high-content screening is gaining significant traction, driven by the pharmaceutical sector's need to speed up drug discovery through high-throughput phenotypic profiling. This trend necessitates the development of specialized assay kits and fluorophores that maintain stability during prolonged automated acquisition cycles and minimize variability in large-scale screening campaigns. Consequently, the market is witnessing a surge in the deployment of automated instrumentation, which serves as a precursor to sustained reagent consumption. For instance, Standard BioTools noted in their 'Fourth Quarter and Full Year 2023 Financial Results' in February 2024 that instrument sales increased by 46% for the full year 2023, signaling a robust expansion in the installed base of high-parameter analysis systems that rely on these advanced consumable formulations.

Key Market Players

Becton, Dickinson and Company
Thermo Fisher Scientific inc.
Merck Millipore Life sciences company
Grace Bio-Labs
Inopat Reagents and Laboratory Equipment
Brunel Microscopes
Cedarlane Labs
PerkinElmer Inc.
Abcam plc

Report Scope

In this report, the Global Microscopy Imaging Reagents Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Microscopy Imaging Reagents Market, By Type

Immunohistochemistry Reagents
Immunocytochemistry Reagents
Immunofluorescence Reagents

Microscopy Imaging Reagents Market, By Application

Biotechnology & Pharmaceutical Companies
Academic & Research Institutions
Others

Microscopy Imaging Reagents Market, By Region

North America
- United States
- Canada
- Mexico
Europe
- France
- United Kingdom
- Italy
- Germany
- Spain
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
South America
- Brazil
- Argentina
- Colombia
Middle East & Africa
- South Africa
- Saudi Arabia
- UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Microscopy Imaging Reagents Market.

Available Customizations:

Global Microscopy Imaging Reagents Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Microscopy Imaging Reagents Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Type (Immunohistochemistry Reagents, Immunocytochemistry Reagents, Immunofluorescence Reagents)
- 5.2.2. By Application (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)
- 5.2.3. By Region
- 5.2.4. By Company (2025)
5.3. Market Map

6. North America Microscopy Imaging Reagents Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By Application
- 6.2.3. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Microscopy Imaging Reagents Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Type
    - 6.3.1.2.2. By Application
- 6.3.2. Canada Microscopy Imaging Reagents Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Type
    - 6.3.2.2.2. By Application
- 6.3.3. Mexico Microscopy Imaging Reagents Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Type
    - 6.3.3.2.2. By Application

7. Europe Microscopy Imaging Reagents Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By Application
- 7.2.3. By Country
7.3. Europe: Country Analysis
- 7.3.1. Germany Microscopy Imaging Reagents Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Type
    - 7.3.1.2.2. By Application
- 7.3.2. France Microscopy Imaging Reagents Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Type
    - 7.3.2.2.2. By Application
- 7.3.3. United Kingdom Microscopy Imaging Reagents Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Type
    - 7.3.3.2.2. By Application
- 7.3.4. Italy Microscopy Imaging Reagents Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Type
    - 7.3.4.2.2. By Application
- 7.3.5. Spain Microscopy Imaging Reagents Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Type
    - 7.3.5.2.2. By Application

8. Asia Pacific Microscopy Imaging Reagents Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By Application
- 8.2.3. By Country
8.3. Asia Pacific: Country Analysis
- 8.3.1. China Microscopy Imaging Reagents Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Type
    - 8.3.1.2.2. By Application
- 8.3.2. India Microscopy Imaging Reagents Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Type
    - 8.3.2.2.2. By Application
- 8.3.3. Japan Microscopy Imaging Reagents Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Type
    - 8.3.3.2.2. By Application
- 8.3.4. South Korea Microscopy Imaging Reagents Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Type
    - 8.3.4.2.2. By Application
- 8.3.5. Australia Microscopy Imaging Reagents Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Type
    - 8.3.5.2.2. By Application

9. Middle East & Africa Microscopy Imaging Reagents Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By Application
- 9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
- 9.3.1. Saudi Arabia Microscopy Imaging Reagents Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Type
    - 9.3.1.2.2. By Application
- 9.3.2. UAE Microscopy Imaging Reagents Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Type
    - 9.3.2.2.2. By Application
- 9.3.3. South Africa Microscopy Imaging Reagents Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Type
    - 9.3.3.2.2. By Application

10. South America Microscopy Imaging Reagents Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Type
- 10.2.2. By Application
- 10.2.3. By Country
10.3. South America: Country Analysis
- 10.3.1. Brazil Microscopy Imaging Reagents Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Type
    - 10.3.1.2.2. By Application
- 10.3.2. Colombia Microscopy Imaging Reagents Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Type
    - 10.3.2.2.2. By Application
- 10.3.3. Argentina Microscopy Imaging Reagents Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Type
    - 10.3.3.2.2. By Application

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments

13. Global Microscopy Imaging Reagents Market: SWOT Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape

15.1. Becton, Dickinson and Company
- 15.1.1. Business Overview
- 15.1.2. Products & Services
- 15.1.3. Recent Developments
- 15.1.4. Key Personnel
- 15.1.5. SWOT Analysis
15.2. Thermo Fisher Scientific inc.
15.3. Merck Millipore Life sciences company
15.4. Grace Bio-Labs
15.5. Inopat Reagents and Laboratory Equipment
15.6. Brunel Microscopes
15.7. Cedarlane Labs
15.8. PerkinElmer Inc.
15.9. Abcam plc